Interleukin-4 receptor alpha polymorphisms in autoimmune myasthenia gravis in a Caucasian population

Human Immunology

Volumn 73, Issue 2, 2012, Pages 193-195

  Pál, Zsuzsanna ^a   Varga, Zsófia ^b   Semsei, Ágnes ^a   Reményi, Viktória ^a   Rózsa, Csilla ^c   Falus, András ^a,d   Illes, Zsolt ^e   Buzás, Edit Irén ^a   Molnar, Maria Judit ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

^c Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Autoimmunity; IL4R; Myasthenia gravis; SNP

Indexed keywords

INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-4;

EID: 84856358856     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.11.001     Document Type: Article

References (17)

1. + T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci 2008, 1132:193-209.
2. Foote L.C., Evans J.W., Cifuni J.M., et al. Interleukin-4 produces a breakdown of tolerance in vivo with autoantibody formation and tissue damage. Autoimmunity 2004, 37:569-577.
3. Ostlie N., Milani M., Wang W., Okita D., Conti-Fine B.M. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice. J Immunol 2003, 170:604-612.
4. + epitope sequences of the acetylcholine receptor. J Neuroimmunol 1999, 95:73-84.
5. Tachdjian R., Mathias C., Al Khatib S., et al. Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med 2009, 206:2191-2204.
6. Kruse S., Japha T., Tedner M., et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999, 96:365-371.
7. Ford A.Q., Heller N.M., Stephenson L., Boothby M.R., Keegan A.D. An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylation. J Immunol 2009, 183:1607-1616.
8. Wenzel S.E., Balzar S., Ampleford E., et al. IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 2007, 175:570-576.
9. Mirel D.B., Barcellos L.F., Wang J., Hauser S.L., Oksenberg J.R., Erlich H.A. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun 2004, 5:138-141.
10. Prots I., Skapenko A., Wendler J., et al. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum 2006, 54:1491-1500.
11. Molnar M.J., Bencsik P. Establishing a neurological - psychiatric biobank: Banking, informatics, and ethics. Cell Immunol 2006, 244:101-104.
12. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893.
13. Monfardini C., Milani M., Ostlie N., Wang W., Karachunski P.I., Okita D.K., et al. Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes. J Neuroimmunol 2002, 123:123-134.
14. Karachunski P.I., Ostlie N.S., Okita D.K., Garman R., Conti-Fine B.M. Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis. J Neuroimmunol 1999, 93:108-121.
15. Huang D., Xia S., Zhou Y., Pirskanen R., Liu L., Lefvert A.K. No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis. J Neuroimmunol 1998, 92:208-211.
16. Stephenson L., Johns M.H., Woodward E., Mora A.L., Boothby M. An IL4R alpha allelic variant, I50, acts as a gain-of-function variant relative to the V50 for STAT6, but not Th2 differentiation. J Immunol 2004, 173:4523-4528.
17. Niks E.H., van Leeuwen Y., Leite M.I., Dekker F.W., Wintzen A.R., Wirtz P.W., et al. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1. J Neuroimmunol 2008, 195:151-156.